TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Giant Biogene Holding Co. Ltd. ( (HK:2367) ) has shared an update.
Giant Biogene Holding Co., Ltd announced the completion of a Vendor Placing and Subscription of new shares under a general mandate. The company successfully placed 35,000,000 shares at HK$66.65 per share, raising approximately HK$2,294 million. The proceeds will be used to develop the company’s core business, including brand promotion, marketing, category expansion, and R&D investment, as well as to replenish liquidity and support general corporate purposes.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd is a company incorporated in the Cayman Islands, primarily involved in the biotechnology industry. The company focuses on developing and expanding its product lines in Class III medical devices, feminine care products, and health products, with a strong emphasis on brand promotion and marketing to enhance its market presence.
YTD Price Performance: 54.51%
Average Trading Volume: 5,594,957
Technical Sentiment Signal: Sell
Current Market Cap: HK$78.84B
See more data about 2367 stock on TipRanks’ Stock Analysis page.